S
Sathish
About Sathish
Data last updated:
Sathish is a Director at Grant Impeco Private Limited (since 2023) and Director at Skytrust Pharmaceutical Private Limited (since 2025). The largest current company by reported revenue is Grant Impeco Private Limited at ₹2.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Grant Impeco Private Limited U47721DL2023PTC411662 | Director | 27 Mar 2023 | 2023 | ₹2.34 Cr (FY 2025) | Active |
| Skytrust Pharmaceutical Private Limited U47721DL2025PTC458236 | Director | 20 Nov 2025 | 2025 | Active |
Board colleagues of Sathish
| Name | DIN | Company | Designation |
|---|---|---|---|
| Maheen Thameem Ansari | 06865620 | Grant Impeco Private Limited , Skytrust Pharmaceutical Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sathish
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sathish
Sathish currently holds 2 directorships: Grant Impeco Private Limited (Director, since 27 Mar 2023, revenue ₹2.34 Cr (FY 2025)); Skytrust Pharmaceutical Private Limited (Director, since 20 Nov 2025).
Sathish was first appointed on 27 Mar 2023 as Director at Grant Impeco Private Limited. The most recent appointment on record is 20 Nov 2025 at Skytrust Pharmaceutical Private Limited.
The current boards of Sathish's companies include Maheen Thameem Ansari (Grant Impeco Private Limited).